Bide Pharmatech Co (SHSE:688073) Change In Inventory: ¥0 Mil (TTM As of Jun. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Bide Pharmatech Co Ltd SHSE:688073

86 GF Score

Price ¥64.15

GF Value ¥64.94

Valuation Fairly Valued

4 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Bide Pharmatech Co Change In Inventory?

Bide Pharmatech Co SHSE:688073 +5.56% 86 Change In Inventory is ¥0 Mil as of Jun. 2026. GuruFocus rates SHSE:688073 with a GF Score™ of 86/100 and a GF Value™ of ¥64.94 (Fairly Valued). The stock has 4 warning signs investors should review.

Bide Pharmatech Co's change in inventory for the quarter that ended in Jun. 2026 was ¥0 Mil. It means Bide Pharmatech Co's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Bide Pharmatech Co's change in inventory for the fiscal year that ended in Dec. 2025 was ¥-232 Mil. It means Bide Pharmatech Co's inventory increased by ¥232 Mil from Dec. 2024 to Dec. 2025 .

Bide Pharmatech Co's Total Inventories for the quarter that ended in Jun. 2026 was ¥935 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Bide Pharmatech Co's Days Inventory for the quarter that ended in Jun. 2026 was 486.66.

Inventory Turnover measures how fast the company turns over its inventory within a year. Bide Pharmatech Co's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.19.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bide Pharmatech Co's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 2.64.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Bide Pharmatech Co (SHSE:688073) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Bide Pharmatech Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	950.630020375	/	178.246114885	*	365 / 4
	=	486.66

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Bide Pharmatech Co's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	178.246114885	/	950.630020375
	=	0.19

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Bide Pharmatech Co's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	950.630020375	/	359.56067498
	=	2.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bide Pharmatech Co Change In Inventory Related Terms

Bide Pharmatech Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for Bide Pharmatech Co's Change In Inventory can be seen below:

Bide Pharmatech Co Change In Inventory Chart

Bide Pharmatech Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

-267.20

-52.81

-196.27

-96.65

-231.94

Bide Pharmatech Co Quarterly Data
	Sep21	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Change In Inventory	Get a 7-Day Free Trial														0.00	0.00	0.00	0.00	0.00

86GF Score

Bide Pharmatech Co Ltd SHSE:688073

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Bide Pharmatech Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of ¥0 Mil mean?

Bide Pharmatech Co (SHSE:688073) has a Change In Inventory of ¥0 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Bide Pharmatech Co and its competitors.

Is Bide Pharmatech Co's Change In Inventory too high?

Bide Pharmatech Co's current Change In Inventory is ¥0 Mil. Overall, Bide Pharmatech Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Bide Pharmatech Co's Change In Inventory compare to ZTS?

Bide Pharmatech Co's Change In Inventory of ¥0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Drug Manufacturers company?

A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Bide Pharmatech Co and its competitors. Bide Pharmatech Co's current Change In Inventory is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bide Pharmatech Co stock overvalued right now?

Based on GuruFocus' analysis, Bide Pharmatech Co (SHSE:688073) is currently considered Fairly Valued. The stock's GF Value™ is ¥64.94, compared to a current price of ¥64.15 — trading 1.2% below its estimated fair value. The current Change In Inventory is ¥0 Mil. Bide Pharmatech Co's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Bide Pharmatech Co (SHSE:688073), the current Change In Inventory is ¥0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bide Pharmatech Co (SHSE:688073) Overvalued in 2026?

Based on GuruFocus' analysis, Bide Pharmatech Co stock appears to be undervalued. The current stock price of ¥64.15 is trading 1.2% below its estimated GF Value™ of ¥64.94. GuruFocus considers Bide Pharmatech Co to be Fairly Valued.

Key valuation signals for SHSE:688073:

Change In Inventory: ¥0 Mil
GF Value™: ¥64.94 vs. price of ¥64.15 (1.2% below fair value)
GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688073 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →